Sanket Shah, General Counsel of Mesa Laboratories Inc /CO/, filed an Initial Statement of Beneficial Ownership (Form 3) on November 12, 2026, disclosing a beneficial interest in restricted stock units as of the event date of November 10, 2026.

Key Highlights

  • Reporting person: Sanket Shah, identified in the filing as General Counsel of Mesa Laboratories Inc /CO/ (NASDAQ:MLAB).
  • Derivative security disclosed: 2,306 Restricted Stock Units, each representing a contingent right to receive one share of the issuer's common stock.
  • Exercise price: $0, with a first exercisable date of November 10, 2027, according to the filing.
  • Vesting schedule: 34% on November 10, 2027; 33% on November 10, 2028; and 33% on November 10, 2029, as stated in the filing.
  • Ownership form: Direct, with no non-derivative securities reported in Table I.
  • Event date: November 10, 2026, as listed in the filing as the date of the event requiring the statement.

Sanket Shah's Initial Beneficial Ownership Disclosure at Mesa Laboratories

According to the Form 3 filed with the SEC on November 12, 2026, Sanket Shah submitted his initial statement of beneficial ownership in connection with his role as General Counsel at Mesa Laboratories Inc /CO/, traded on NASDAQ:MLAB. The filing was signed by John Sakys under Power of Attorney by Sanket Shah and covers a triggering event dated November 10, 2026.

The filing reports no non-derivative securities in Table I. In Table II, the filing discloses 2,306 Restricted Stock Units classified as derivative securities. The filing states that "each RSU represents a contingent right to receive one share of the Issuer's common stock." The conversion or exercise price is listed as $0, and ownership is recorded as direct.

The RSUs are described in the filing as vesting in three tranches: 34% on November 10, 2027, 33% on November 10, 2028, and 33% on November 10, 2029. No expiration date is listed for the RSUs, and the underlying security is identified as common stock. The reporting person's address is listed as c/o ViewRay, Inc., 2 Thermo Fisher Way, Oakwood Village, Ohio 44146, as it appears in the filing.

What Was Disclosed

Sanket Shah, General Counsel, filed an initial beneficial ownership statement disclosing 2,306 Restricted Stock Units in Mesa Laboratories Inc /CO/ common stock, held directly, with a three-tranche vesting schedule beginning November 10, 2027.